Literature DB >> 23123996

Effects of percutaneous stimulation of both sympathetic and parasympathetic cardiac autonomic nerves on cardiac function in dogs.

Mariko Kobayashi1, Seiichiro Sakurai, Tohru Takaseya, Akira Shiose, Hyun-Il Kim, Masako Fujiki, Jamshid H Karimov, Raymond Dessoffy, Alex Massiello, Allen G Borowski, David R Van Wagoner, Eugene Jung, Kiyotaka Fukamachi.   

Abstract

OBJECTIVE: Augmentation of left ventricular (LV) contractility and heart rate (HR) by sympathetic nerve stimulation and amelioration of heart failure by vagal nerve stimulation has been reported. However, the effects of concomitant electrical stimulation of both sympathetic and parasympathetic cardiac nerves in tissues such as those of the cardiac plexus remain unclear. This study sought to assess acute changes in cardiac function and hemodynamics in response to endovascular cardiac plexus stimulation (CPS).
METHODS: Twelve dogs received endovascular CPS via a bipolar catheter within the right pulmonary artery. Stimulation frequency (20 Hz) and pulse width (4 milliseconds) were fixed; voltage varied (range, 15-60 V).
RESULTS: Results fell into three categories: 1, no response (n = 4); 2, an increase in systemic arterial pressure that was dependent on electrode placement (n = 4); and 3, a very reproducible and stable increase in aortic pressure (n = 4). In the third group, mean systolic aortic pressures, maximum value of the first derivative of LV pressure, and LV stroke work increased with stimulation (P < 0.02 for all parameters) as did cardiac output, end-systolic elastance, and preload recruitable stroke work (P = 0.03). Systemic and pulmonary vascular resistance, central venous pressure, pulmonary arterial pressure, and HR remained unchanged (P > 0.05).
CONCLUSIONS: In contrast to conventional inotropic agents, endovascular CPS induced significant and selective increases in LV contractility without increasing HR. Efforts to optimize electrode placement and fixation will improve the reproducibility of endovascular CPS treatment.

Entities:  

Mesh:

Year:  2012        PMID: 23123996     DOI: 10.1097/IMI.0b013e31826f14ff

Source DB:  PubMed          Journal:  Innovations (Phila)        ISSN: 1556-9845


  3 in total

Review 1.  Heart failure with preserved ejection fraction: mechanisms, clinical features, and therapies.

Authors:  Kavita Sharma; David A Kass
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

2.  Cardiac Pulmonary Nerve Stimulation (CPNSTM): A Novel Treatment for Acute Decompensated Heart Failure.

Authors:  Steve Goedeke; Sitaramesh Emani; William T Abraham; Megan M Brandt; Jeremy A Schaefer
Journal:  JACC Basic Transl Sci       Date:  2022-04-04

Review 3.  Device-based therapy for decompensated heart failure: An updated review of devices in development based on the DRI2P2S classification.

Authors:  Cristiano de Oliveira Cardoso; Abdelmotagaly Elgalad; Ke Li; Emerson C Perin
Journal:  Front Cardiovasc Med       Date:  2022-09-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.